NYSE:RNRRenaissanceRe Stock Price, Forecast & News

RenaissanceRe's stock was trading at $155.96 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RNR stock has increased by 11.8% and is now trading at $174.29. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RenaissanceRe in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for RenaissanceRe.

RenaissanceRe is scheduled to release its next quarterly earnings announcement on Tuesday, July 28th 2020. View our earnings forecast for RenaissanceRe.

RenaissanceRe will be holding an earnings conference call on Tuesday, July 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

RenaissanceRe Holdings Ltd. (NYSE:RNR) posted its quarterly earnings results on Wednesday, May, 6th. The insurance provider reported $0.76 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.87 by $3.11. The insurance provider earned $1.27 billion during the quarter, compared to analyst estimates of $1.03 billion. RenaissanceRe had a net margin of 9.16% and a return on equity of 6.06%. The firm's revenue was up 36.7% compared to the same quarter last year. During the same period in the previous year, the business earned $3.60 EPS. View RenaissanceRe's earnings history.

RenaissanceRe announced a quarterly dividend on Tuesday, May 19th. Stockholders of record on Monday, June 15th will be given a dividend of $0.35 per share on Tuesday, June 30th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 0.80%. The ex-dividend date of this dividend is Friday, June 12th. View RenaissanceRe's dividend history.

7 equities research analysts have issued 1 year price targets for RenaissanceRe's shares. Their forecasts range from $158.00 to $229.00. On average, they expect RenaissanceRe's stock price to reach $193.43 in the next year. This suggests a possible upside of 11.0% from the stock's current price. View analysts' price targets for RenaissanceRe.

Media headlines about RNR stock have been trending very negative on Monday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. RenaissanceRe earned a news sentiment score of -3.2 on InfoTrie's scale. They also gave news coverage about the insurance provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about RenaissanceRe.

Some companies that are related to RenaissanceRe include Everest Re Group (RE), Alleghany (Y), Reinsurance Group of America (RGA), Enstar Group (ESGR), Greenlight Capital Re (GLRE), Maiden (MHLD) and Partnerre (PRE.PH). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other RenaissanceRe investors own include Verizon Communications (VZ), Xilinx (XLNX), Advanced Micro Devices (AMD), Home Depot (HD), Exxon Mobil (XOM), Taiwan Semiconductor Mfg. (TSM), Zoetis (ZTS), Fortinet (FTNT), NVIDIA (NVDA) and Universal Display (OLED).

RenaissanceRe trades on the New York Stock Exchange (NYSE) under the ticker symbol "RNR."

RenaissanceRe's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Dalton Greiner Hartman Maher & Co. (0.18%), Envestnet Asset Management Inc. (0.06%), Whittier Trust Co. (0.02%), Whittier Trust Co. of Nevada Inc. (0.01%), 6 Meridian (0.00%) and Livforsakringsbolaget Skandia Omsesidigt (0.00%). Company insiders that own RenaissanceRe stock include Aditya Dutt, Henry Klehm III, Ian D Branagan, Jonathan Paradine, Kevin Odonnell, Ross Curtis and Sean G Brosnan. View institutional ownership trends for RenaissanceRe.

RNR stock was sold by a variety of institutional investors in the last quarter, including Livforsakringsbolaget Skandia Omsesidigt, and 6 Meridian. Company insiders that have sold RenaissanceRe company stock in the last year include Jonathan Paradine, Kevin Odonnell, and Sean G Brosnan. View insider buying and selling activity for RenaissanceRe.

RNR stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Whittier Trust Co. of Nevada Inc., Whittier Trust Co., and Dalton Greiner Hartman Maher & Co.. View insider buying and selling activity for RenaissanceRe.

Shares of RNR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of RNR stock can currently be purchased for approximately $174.29.

RenaissanceRe has a market capitalization of $7.67 billion and generates $4.20 billion in revenue each year. The insurance provider earns $748.80 million in net income (profit) each year or $9.13 on an earnings per share basis.

The official website for RenaissanceRe is www.renre.com.

RenaissanceRe's mailing address is RENAISSANCE HOUSE 12 CROW LANE, PEMBROKE D0, HM 19. The insurance provider can be reached via phone at 441-295-4513 or via email at [email protected]